EUR/USD Forecast: Sell opportunity? Why the current calm may turn to a fresh downfall
Premium|Take advantage of 50% OFF on your first month.
50% OFF and access to ALL our articles and insights.
You have reached your limit of 5 free articles for this month.
Take advantage of the Special Price just for today!
50% OFF and access to ALL our articles and insights.
Subscribe to Premium- EUR/USD has bounced amid a marginally better market mood.
- Concerns about EU vaccines and other factors may cause a fresh fall.
- Friday's four-hour chart is pointing to a fresh downfall.
Dead-cat bounce. Again. That pattern of a significant downfall followed by a minor recovery and then a fresh dive is typical to EUR/USD – and maybe in play once again. The factors that have enabled the recovery are weak and may reverse swiftly.
EU leaders toned down their rhetoric regarding banning exports of vaccines amid concerns of hurting supply chains. Have cooler minds prevailed? The bloc still allows blocking of immunization shipments out of the EU and seem especially keen on punishing AstraZeneca – the partially British-owned firm which is Brussels' favorite punching bag.
Coronavirus cases continue rising in the old continent and are also causing a rift between the largest countries – Germany will now ask people coming from France to show a negative PCR test due to rising infections. The move has caused tensions between Paris and Berlin, which have worked closely together in this crisis.
The German IFO Business Climate will likely show a minor uptick in confidence, but that is priced in after robust Purchasing Managers' Indexes released earlier this week.
On the other side of the pond, investors were encouraged by the drop of US jobless claims to 684,000, the lowest since the pandemic broke out. However, Personal Spending and Personal Income due out on Friday may show a drop in February after a stimulus-related jump in January. Core PCE, the Federal Reserve's preferred gauge of inflation, will likely remain subdued as well.
The February Grab-Bag Preview: Personal Income, Spending, Core PCE Prices
Another source of optimism is President Joe Biden's pledge to inject 200 million vaccine doses in his first 100 days in office. On the other hand, COVID-19 infections have bottomed out in the US and have begun rising. The immunization campaign is running at full speed, but there is still room to run in order to approach herd immunity that would significantly depress the disease.
All in all, the current upward swing in the mood will likely be temporary.
EUR/USD Technical Analysis
Euro/dollar is suffering from downside momentum on the four-hour chart and is trading below the 50, 100 and 200 Simple Moving Averages. The Relative Strengh Index is just above 30, outside oversold conditions and implying further falls are on the cards.
Support awaits at the new 2021 trough of 1.1760, followed closely by 1.1745, a cushion from November. Further down, 1.1695 and 1.16 may come into play.
Resistance is at 1.18, the round number that previously supported EUR/USD, and then by 1.1845, which was a low point in early March. Further above, 1.1875 and 1.1905 are eyed.
Global markets are positioned for a robust recovery, but where is the proof?
- EUR/USD has bounced amid a marginally better market mood.
- Concerns about EU vaccines and other factors may cause a fresh fall.
- Friday's four-hour chart is pointing to a fresh downfall.
Dead-cat bounce. Again. That pattern of a significant downfall followed by a minor recovery and then a fresh dive is typical to EUR/USD – and maybe in play once again. The factors that have enabled the recovery are weak and may reverse swiftly.
EU leaders toned down their rhetoric regarding banning exports of vaccines amid concerns of hurting supply chains. Have cooler minds prevailed? The bloc still allows blocking of immunization shipments out of the EU and seem especially keen on punishing AstraZeneca – the partially British-owned firm which is Brussels' favorite punching bag.
Coronavirus cases continue rising in the old continent and are also causing a rift between the largest countries – Germany will now ask people coming from France to show a negative PCR test due to rising infections. The move has caused tensions between Paris and Berlin, which have worked closely together in this crisis.
The German IFO Business Climate will likely show a minor uptick in confidence, but that is priced in after robust Purchasing Managers' Indexes released earlier this week.
On the other side of the pond, investors were encouraged by the drop of US jobless claims to 684,000, the lowest since the pandemic broke out. However, Personal Spending and Personal Income due out on Friday may show a drop in February after a stimulus-related jump in January. Core PCE, the Federal Reserve's preferred gauge of inflation, will likely remain subdued as well.
The February Grab-Bag Preview: Personal Income, Spending, Core PCE Prices
Another source of optimism is President Joe Biden's pledge to inject 200 million vaccine doses in his first 100 days in office. On the other hand, COVID-19 infections have bottomed out in the US and have begun rising. The immunization campaign is running at full speed, but there is still room to run in order to approach herd immunity that would significantly depress the disease.
All in all, the current upward swing in the mood will likely be temporary.
EUR/USD Technical Analysis
Euro/dollar is suffering from downside momentum on the four-hour chart and is trading below the 50, 100 and 200 Simple Moving Averages. The Relative Strengh Index is just above 30, outside oversold conditions and implying further falls are on the cards.
Support awaits at the new 2021 trough of 1.1760, followed closely by 1.1745, a cushion from November. Further down, 1.1695 and 1.16 may come into play.
Resistance is at 1.18, the round number that previously supported EUR/USD, and then by 1.1845, which was a low point in early March. Further above, 1.1875 and 1.1905 are eyed.
Global markets are positioned for a robust recovery, but where is the proof?
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.